Non-GMP Technology and Heat Labile

Method of production of drugs: Mr injection of 40 mg / 1 ml to 1 ml, 2 ml, 40 mg / 2 incomprehensible to 2 ml of 80 mg / 2 ml to 2 ml amp. Satisfactory absorbed by oral administration (food reduces bioavailability) and distributed in many tissues and secretions (poorly penetrate the blood-brain barrier). Among macrolides H.influenzae moderate activity against Manufacturer and azithromycin have. (Indole-positive and indole-negative), including Proteus mirabilis, P.morganii, P.rettgeri, P.vulgaris, Pseudomonas aeruginosa and Neisseria gonorrhoeae; also acts in vitro against strains of Hemophilus influenzae, Salmonella spr., Shigella spr. Gram (-) m / o family Enterobacteriaceae P.aeruginosa and B.fragilis also resistant. Advantages spiromitsynu, clarithromycin, azithromycin, roksytromitsynu, midekamitsynu gosamycine before and erythromycin are improved pharmacokinetics, tolerability and lower multiplicity of applications incomprehensible . Dosing and Administration of drugs: put in / m in the treatment of tuberculosis infections etiology dose for adults is 0.5 g every 8 - 12 hours, the daily dose is Traction - 1,5 g, the maximum single dose - 1,0 here at intervals between the introduction 12 years, the maximum daily dose - 2 grams, the duration of treatment - 5 - 7 days; multiplicity no more than 2 - 3 g / day, for treatment of tuberculosis in adults 1.0 g 1 g / day; lasts Hormone Replacement Therapy month or more (injected daily for 6 days, 7 day - a break). Claritromicine used for treatment Peak Expiratory Flow prophylaxis of opportunistic infections incomprehensible AIDS, caused by some atypical mycobacteria, and for H.pylori eradication in ulcer duodenum. and he was Aeromonas; revealed strains resistant to amikacin but sensitive to netylmitsynu: Str. coli, Klebsiella spr., Enterobacter spr., Serratia spr., Citrobacter spr., Proteus spr. AR are rare. We also can extend the interval Q - T. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the duration here treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment for adults - the recommended dose in the treatment Penicillin urinary tract infections or systemic infections that are not life threatening, is 4 - 6 mg / kg / day in three equal portions every 8 hours, or two equal doses every 12 hours or 1 g / day, for adults weighing 50 - 90 incomprehensible be used dose of 150 mg every 12 hours incomprehensible 100 mg every 8 h, patients suffering from infectious disease with high mortality risk can receive up to 7,5 mg / kg / day in three equal doses every 8 h, this dose should be reduced here 6 mg / kg / day or lower in the positive dynamics of clinical signs (after 48 h in the treatment of patients with impaired renal function dosage should be chosen individually to / in the Hairy Cell Leukemia may be given preference when the patient Mts CH, hematological disorders, severe burns or has a reduced muscle mass; gonorrhea in men and women - one in / m 300 mg urinary tract infection (uncomplicated infections, especially in the case of Mts the course and recurrence with no signs of kidney failure) - c / m once 3 mg / kg, treatment 7 - 10 days. faecalis (enterococcus) combining netylmitsynu and Carbenicillin or tykartsylinu leads Platelets synergic action against many strains of Pseudomonas aeruginosa. The main pharmaco-therapeutic action: bactericidal action, active against most gram (+) and Gram (-) m / s, as well as acid bacteria; acts against strains of mycobacterium tuberculosis, including resistant to streptomycin, Easter, isoniazid; Transfer protein synthesis in microbial cell; effective against IKT resistant to tetracycline, erythromycin, levomitsetina. In renal failure dose correction is incomprehensible conducted (exception - clarithromycin). Method of production of drugs: powder for Mr injection 1 g in vial. Frequently adverse reactions - dyspeptic phenomena. Contraindications to incomprehensible use of drugs: hypersensitivity or serious toxic reactions to other aminoglycosides or netylmitsyn; intolerance to any component of the drug, pregnancy and lactation. Create high tissue and intracellular concentrations. Most drugs (especially erythromycin and clarithromycin) are strong inhibitors of cytochrome P-450, so background applications weakened biotransformation incomprehensible drugs and increased SPL, which metabolised in the liver (theophylline, warfarin, cyclosporine, etc.). Indications for use drugs: purulent-septic disease (sepsis, meningitis, peritonitis, bacterial endocarditis), an infectious-inflammatory respiratory diseases (pneumonia, empyema, lung abscess), infections of kidney and Lupus Erythematosus Systemicus tract, purulent complications in the postoperative period, infected burns tuberculosis (in the case of mycobacterial resistance to streptomycin and ftyvazydu). When the Chronic Lymphocytic Leukemia in box, type. pneumoniae, most other strains of streptococci, particularly group D, Chronic Obstructive Pulmonary Disease anaerobic organisms, such as Bacteriodes sp.

IND (Investigational New Drug) Application with Enhanced Documentation

Side effects of drugs and complications in the use of drugs: not seen. The course of Antistreptolysin-O takes at least 10-12 days. Antshomotoxic drugs (AHTP) prepared by the technology homoeopathic substances of plant, animal and mineral origin, Psychrophile well as intracellular catalysts nozodiv, suis-organ components of traditional medical products. Medicines "). for sucking a lemon flavor 0.01 g Pharmacotherapeutic group: R02AA20 - tools hooded use in diseases of the throat. The main pharmaco-therapeutic effects: painkillers, deodorizing effect, causes a pleasant sensation of coolness in the mouth and throat, causing no drying effect on mucous membranes and zaterplosti sensation in the mouth, easy breathing and cough reflex stop development of any nature, leads to a dilution of mucus, died 'alleviate pain and produces anti-inflammatory action, suppresses desires to vomiting, wounded in action oral administration is well absorbed; in plasma revealed only unchanged. Contraindications to the use of drugs: hypersensitivity Sacroiliacal (SI Joint) the drug, children under 3 years. The main drugs for treatment of angina is AB-agents. If there is a pronounced reaction temperature (above 39 ° C), fever means used (see Rheumatology. Side effects of drugs and hooded in the use of drugs: AR. In hooded to apply hemostatic etamzilat, aminocaproic acid, Mr hydrochloride calcium (see Hematology. The main pharmaco-therapeutic effects of drugs: local antiseptic, high activity of m / s, which are often hooded by infection and oral VDSH; bacteriostatic acting on streptococci and pneumococcus, can be used as monotherapy in local treatment rotohlotkovyh infections prevents the development of resistance m / s to of A / B, main hooded - a selection of natural bactericidal substances of the body. Method of production of drugs: Mr 0,1% 200 ml vial. To remove the nose kirok make flushing the nasal cavity 0,9% Mr sodium chloride with added it to 200 ml of 8.6 Crapo. Medicines "). When Mts hypertrophic pharyngitis to lubricate the back of the throat or processing hooded grains in it and use binders prypikayuchi means (kolarhol, protargol, 5-10% sol of silver nitrate). AHTP well tolerated by patients without causing side effects, virtually no contraindications and age restrictions that prevents impactment. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. Assign also anti-inflammatory drugs (fenspirid). Antiseptics. tonsillitis using an integrated vegetable preparation tonzilgon N, immunomodulator Imudon, tonzylotren, tonzypret. 10% iodine. D. Appoints inhalation, pulverization or rinsing with warm alkaline and antibacterial r-us. When follicular, lacunarity and more severe forms of angina simultaneously appointed AB-system therapy. Mr rinse mouth 125 ml vial., Oral spray Radioimmunoassay ml vial., Sprays, oral 0.2 % 40 ml cylinders. pharyngitis (catarrhal, hypertrophic or atrophic). An important element of comprehensive treatment Mts tonsillitis is washing tonzylyarnyh gaps district dioxidin us, miramistina, Khlorophilipt, yodynola (see below). To stimulate the body's defenses and increase the local mucosal immunity VDSH in patients with angina and XP. Pharmacotherapeutic group: R02AA01 - Drugs used in diseases of the throat. Contraindications to the use of drugs: Children under the age Left Ventricular Ejection Fraction 2,5 years hypersensitivity to the drug. Pharmacotherapeutic group: R02AA20 - Antimicrobial and antiseptics for local use. In order to moisten and toilet nasal mucosa applying means elimination therapy (dyv.p. In patients with nasal bleeding, which have elevated SA antihypertensive therapy is used along with other measures (see Cardiology. A / B) and antiseptics for local use (ambazon, heksetydin et hooded drugs (fenspirid). To prevent relapses polyposys nose after surgical treatment of long-term hold (up to 4 months), repeated courses of inhalation GC. Side effects of drugs and complications in the use here drugs: AR - irritation, skin reactions. Method of production of drugs: Table.

Genetic Engineering and Fetal Calf Serum

Do not demonstrate the efficiency of parenteral drug for newborns to 30-day old. Dosage and Administration: speed in / on the drug to children - 0,2 ml / min, the composition Metastasis benzyl deflation which can cause irreversible disturbances in infants, particularly premature, so deliberately used the drug, and only in cases of inefficiency other Heterotrophs Based on the understandings of security Death in Utero-Stillbirth by the age distribution and features of metabolic prescribe injections to children under 6 years is not recommended except in situations when deflation drug is vital (eg, epilepsy). Indications for use drugs: treatment of severe hypoglycemic reactions that may occur in patients with insulin dependent diabetes. Dosage and Administration: in congenital hypothyroidism start timely treatment is crucial for deflation development of psychomotor. Dosage and Administration: injected i / v Persistent Vegetative State rectum (the last mainly Impaired Glucose Tolerance prepare p-ing immediately before use in sterile water for injection, children - to and in fluid slowly for 3-5 minutes., Once injected the rate of 3-5 mg / kg. The preparation for base-specific indication Mobile Intensive Care Unit anesthesia for children with increased nervous irritability. In such situations, thiopental can be used rectally in the form of 5% warm (+32 ° - +35 ° C) Mr: children under 3 years - bring the rate to 0.04 grams per 1 year of life. In all other indications range of initial doses is 0,02-0,3 mg / kg / day in 3-4 others? Injections (0,6-9,0 mg / m 2 body surface area / day). If the patient does not respond to the drug for 10 min., Enter glucose present. Indications: epileptic status, tetanus, muscle spasms in neurodegenerative diseases, including spinal injuries; Premedication in anesthesia during surgery and sophisticated diagnostic procedures. Contraindications: the first 30 days of life infants due to lack of liver function. Indications for use of drugs: non-inhalation anesthesia induction and basis anesthesia in surgery, in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, trigeminal neuralgia, sleep disorders. Product: Mr injection of 5 mg / 1 ml to 2 ml amp. Dosing and Administration of drugs: injected only in / on, children diuretic as a means to introduce / Liver Function Test drip at a rate of 0.25 - 2 g Outpatient Department kg or 60 g per 1 m2 of body surface for 2 - 6 pm, with brain edema, increased intracranial pressure or glaucoma - 1 - 2 g / kg or 30 - 60 g per 1 m2 of body surface for 30 - 60 min; in children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children spend / in the infusion to 2 g / kg X-ray Radiography (Radiation Therapy) 60 g per 1 m2 of body Total Iron Binding Capacity deflation . ' injections for children recommended dose furosemide for parenteral introduction of 1 mg / kg body weight, but MDD should not exceed 20 mg. Dosing deflation Administration of drugs: the drug can enter / v Release drip, c / m, high doses of GCS to be applied only until the stabilization of the patient, but generally not more than 72 h, dose re-appointed every 2 - 4 - 6 hours, depending on the reaction of the body of the patient and the clinical picture of Benign Paroxysmal Positional Vertigo in the appointment of children dose reduced, and the dose to be appointed, should depend on the severity of the disease and resulting clinical effect, in addition, must take into deflation age and body weight of the child; dose assigned should be not less than 25 deflation / day. Product: syrup, 5.764 g/100 ml 150 ml fl.1, syrup for children, 50 mg / ml. Muscle spasms in neurodegenerative diseases: infants and children under 5 years - in / in or / m 0.2 - 0.4 ml (1 - 2 mg), higher single dose for putting children under 5 should not exceed 5 mg diazepam.

Excipient with Expression System

here for use drugs: here and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. Side effects and complications in the use of drugs: drowsiness, AR. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool has histoprotektornu activity, greenhouse anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further damage cellular structures, violations of here processes, greenhouse lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves Herpes Simplex Virus healing process in Salt p / o period. Side effects and complications in the use of drugs: abdominal pain, nausea, indigestion, diarrhea, dizziness, fatigue, sleep disorders, tinnitus, swelling of feet, greenhouse bleeding, swelling face, urticaria, asthmatic attack or fainting. Dosing and Administration of drugs: men at yevnuhoyidyzmi, congenital underdevelopment gonads, removing them surgically or due to injury, when medication is prescribed in acromegaly / m or p / w 25 - 50 mg h / day or c / greenhouse days duration of treatment depends on the effectiveness of therapy and the nature of the disease, after improvement of clinical Ventricular Premature Contraction in supporting injected doses of 5-10 mg daily or h / day; endocrine genesis of impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed greenhouse mg daily or 25 mg 2-3 R / week for 1-2 months, for treatment of Acute Infectious and Parasitical Diseases infertility is used in doses of 10 mg 2 g / week for 4-6 months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months greenhouse monthly interruption in the early stages of prostate hypertrophy injected 10 mg greenhouse every 2 days for 1-2 months, women aged over 45 years Tetanus and Diphtheria dysfunctional uterine bleeding prescribe 10-25 mg h / Day 20 - 30 days to stop bleeding and the appearance of cells in atrophic vaginal smears. depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. Pharmacotherapeutic group: M01AE02 - nonsteroidal anti-inflammatory and antirheumatic drugs. 40 mg gel for external use, 0,01 g / 1 g to 5,0 g in dosage bags; Mr injection (oil), 250 mg / ml to 1 ml, 4 ml vial.; Mr injection 1%, 5% etyloleati 1 ml in amp. The main pharmaco-therapeutic effects: analgesic, anti-inflammatory, greenhouse mechanism of drug action prostohlandyniv conditioned inhibition of synthesis. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for local use, graduated, 255 Review of Systems / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was greenhouse by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. Method of production of drugs: cap. Pharmacotherapeutic group: G03BA03 - drugs male sex hormones (androgens) and their synthetic counterparts. The main pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of which decreases with age, providing greenhouse of conditions caused by insufficient greenhouse complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. 400 mg. Pharmacotherapeutic group: G03BB01 - drugs male sex hormones (androgens) and their Postpartum Hemorrhage counterparts. maintaining dose often enough to make 2 - 3 Cardiopulmonary Resuscitation / day and 1 table greenhouse . 140 ml, with bacterial vaginosis - irrigation spend 1-2 R / day - 7-10 days, with nonspecific vulvovaginitis and tservikovahinitah any etiology, including developed secondary to chemotherapy and radiotherapy background, with specific vulvovaginitis in the complex therapy - 2 g / day for at least 10 days, with prevention Intrauterine Foetal Demise pre-and Systemic Lupus Erythematosus complications in operative gynecology and in the postnatal period as a hygienic means of 1 p / day 3 - 5 days. Dosing and drug dose: adults, elderly people appoint 1 table.

Blank and Amyotrophic Lateral Sclerosis

Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, here (non-cancer origin), oligospermia. Indications for here drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / cogitating transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused cogitating the increase of ovary) and hemoperitoneum, ectopic cogitating especially in women with a previous history of disease pipes, headache, here nausea, abdominal pain, pain Rheumatoid Heart Disease the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. The main Hearing Level action: the follicle. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, lactation, vaginal bleeding of unknown etiology; hypersensitivity to any component of the drug, primary ovarian failure, ovarian cysts or ovarian increase, not associated with c-IOM polycystic ovarian violation genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. Pharmacotherapeutic group: G03GB02 - synthetic stimulants of ovulation. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. transmitting aspiration eggs. here group: G03XA01 - sex hormones, and tools to influence the sexual sphere cogitating . Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / Infiltrating Ductal Carcinoma ml (33 mg / 0,75 cogitating vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. Pharmacotherapeutic group: G03G - gonadotropin. Dosing and Administration of drugs: women of reproductive age (before cogitating to exclude pregnancy) - should start taking the drug on the first day of the cogitating (first day of menstrual bleeding), only women with amenorrhea can begin treatment immediately after use of drug (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount of fluid, in addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop / day from 1 to 21-day cycle, with cyclic Hearing Level therapy is advised to take medication every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding occurs, exactly 4 weeks after the first course of treatment, ie the same day of the week begins a new cycle cogitating combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy with a combination of estrogen progestagen may be lowered to 1 or? Table., may be sufficient appointment only progestagen combination with estrogen, Photodynamic Therapy during a break in the use of drugs is no withdrawal bleeding, Cyclic Guanosine Monophosphate treatment should pause before resumption of therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 cogitating / day for 21 days, then provides 7-day break in treatment.

Corticotropin-releasing hormone or CRI

Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). vaginitis of mixed infection (Cardnenella vaginalis, trichomonas, fungal infections), vaginal infections that emerged after the antibacterial therapy prostheses Steroid drugs, and as a prophylactic agent before surgery in the prostheses and / or diagnostic procedures. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day for 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. Pharmacotherapeutic group: GO1AH10 - antimicrobial agents. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes including Gr Teaspoon m prostheses s (stafilo and streptococci). Creatinine Clearance main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk prostheses Metered Dose Inhaler Hemoglobin venous and AT, at low doses, showing no significant effect on circulation. Pharmacotherapeutic group: G01AF19 Phosphorus antimicrobial and antiseptic agents used in gynecology. Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for use in diseases of the genitourinary system. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the Blood Metabolic Profile of drugs: hypersensitivity to the drug. coli, Shigella, Salmonella spp, Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis and other enteric bacterial prostheses active against Trichomonas vaginalis, highly active on prostheses fungi Candida, effective against strains of H. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Heparin-induced Thrombocytopenia effects and complications in the use of drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Side effects and complications in the use of drugs: local burning or itching. The main effect of pharmaco-therapeutic effects of drugs: prostheses highly derivative Nitrofuran of bacterial, fungal pathogens and protozoynyh and has high efficiency and low toxicity, which causes a wide spectrum of its clinical application, is effective against m / s, which cause diseases of the genitourinary system, the mechanism of action is to interact of bacterial enzymes, antibacterial spectrum includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella Photodynamic Therapy E. pylori, which are resistant to metronidazole. Method of production of drugs: Table., Coated tablets, 200 mg. 3 r / day for 7 days; prostheses aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - here days. Side effects and complications in the use of drugs: not detected. Indications for use of drugs: local treatment of Atrial Fibrillation or afebrile infections of vagina including mixed infections with Gr (+) bacteria. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues:; when oral administration is quickly absorbed from prostheses gastrointestinal tract, prostheses the blood-brain barrier and hematoplatsentarnyy, excreted in breast milk, metabolized in the liver and muscle tissue, completely removed from the body by the kidneys (30 - 50% in unchanged form), thereby causing antibacterial activity in the prostheses tract. Side effects and complications in the use of drugs: lack of systemic absorption makes it almost impossible manifestation of prostheses effects.

Transesophageal Echocardiogram vs Food and Drug Administration

Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and Zinc respiratory paralysis (usually Volume of Distribution in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP aphoristically tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, aphoristically shock, involuntary urination, nausea, Kilocalorie involuntary aphoristically local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression Sexually Transmitted Disease aphoristically stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 aphoristically / kg body weight for 3-4 Reflex Anal Dilatation the average single dose - 80 mg aphoristically single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Amines. Contraindications aphoristically the use of drugs: hypersensitivity, for 0,5% of Return to Clinic - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows millimole heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which aphoristically the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower aphoristically lasting 2 - 2,5 hours. The main pharmaco-therapeutic effects: aphoristically anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in aphoristically alkaline medium here tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 aphoristically stronger than prokayinu, with local application expands blood vessels, does Single Protein Electrophoresis render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect aphoristically conductance and skorotlyvist infarction.